Does RISPERIDONE Cause Neoplasm malignant? 26 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Neoplasm malignant have been filed in association with RISPERIDONE (Risperidone). This represents 0.0% of all adverse event reports for RISPERIDONE.
26
Reports of Neoplasm malignant with RISPERIDONE
0.0%
of all RISPERIDONE reports
8
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm malignant From RISPERIDONE?
Of the 26 reports, 8 (30.8%) resulted in death, 2 (7.7%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISPERIDONE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does RISPERIDONE Cause?
Gynaecomastia (24,453)
Off label use (10,376)
Abnormal weight gain (9,418)
Weight increased (6,885)
Emotional disorder (5,809)
Product use in unapproved indication (5,551)
Drug ineffective (5,232)
Injury (4,447)
Hyperprolactinaemia (4,124)
Galactorrhoea (3,513)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which RISPERIDONE Alternatives Have Lower Neoplasm malignant Risk?
RISPERIDONE vs RITALIN
RISPERIDONE vs RITLECITINIB
RISPERIDONE vs RITODRINE
RISPERIDONE vs RITONAVIR
RISPERIDONE vs RITUXAN